A compounded form of imiquimod, a topical immune response modifier, showed promise as a treatment for ocular surface ...

Central venous catheter-related blood stream infection (CRBSI) is a major cause of morbidity and mortality in patients with end-stage renal disease treated with chronic hemodialysis. Risk factors ...